"Organometallic Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Descriptor ID |
D009942
|
| MeSH Number(s) |
D02.691
|
| Concept/Terms |
Organometallic Compounds- Organometallic Compounds
- Compounds, Organometallic
- Metallo-Organic Compounds
- Compounds, Metallo-Organic
- Metallo Organic Compounds
- Metalloorganic Compounds
- Compounds, Metalloorganic
|
Below are MeSH descriptors whose meaning is more general than "Organometallic Compounds".
Below are MeSH descriptors whose meaning is more specific than "Organometallic Compounds".
This graph shows the total number of publications written about "Organometallic Compounds" by people in this website by year, and whether "Organometallic Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 1 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 2 | 3 |
| 2004 | 1 | 3 | 4 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 0 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 1 | 2 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 1 | 4 |
| 2014 | 3 | 1 | 4 |
| 2015 | 3 | 1 | 4 |
| 2016 | 0 | 3 | 3 |
| 2017 | 1 | 1 | 2 |
| 2018 | 4 | 2 | 6 |
| 2019 | 0 | 3 | 3 |
| 2020 | 1 | 2 | 3 |
| 2021 | 1 | 1 | 2 |
| 2024 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organometallic Compounds" by people in Profiles.
-
A FAPa-activated MRI nanoprobe for precise grading diagnosis of clinical liver fibrosis. Nat Commun. 2024 09 13; 15(1):8036.
-
Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial). Sci Rep. 2024 04 18; 14(1):8986.
-
Causal effect of serum 25 hydroxyvitamin D concentration on cardioembolic stroke: Evidence from two-sample Mendelian randomization. Nutr Metab Cardiovasc Dis. 2024 May; 34(5):1305-1313.
-
A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran. Helicobacter. 2024 Jan-Feb; 29(1):e13061.
-
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study. Helicobacter. 2021 Jun; 26(3):e12801.
-
Pediatric applications of Dotatate: reply to Shulkin et al. Pediatr Radiol. 2021 03; 51(3):497-498.
-
T1-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T. J Cardiovasc Magn Reson. 2020 12 10; 22(1):85.
-
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI. Clin Cancer Res. 2020 09 15; 26(18):5007-5018.
-
Pediatric applications of Dotatate: early diagnostic and therapeutic experience. Pediatr Radiol. 2020 06; 50(7):882-897.
-
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A. Invest Radiol. 2019 11; 54(11):697-703.